Genomics and the Genetics of ALS
Time & Location
About the Event
We are excited to host EverythingALS Community Event: Genomics and the Genetics of ALS.
We invite you to join us and other ALS patients and families to engage in a positive setting of collaboration and community.
The meeting will be on Wednesday, January 13th 2021 at 4:00 pm PDT
-5:00pm Mountain Time
-6:00pm Central Time
-7:00pm Eastern Time
The meeting will be approximately 30-45mins long followed by an open forum.
Once you RSVP the Zoom details with password will be sent via email. Watch out for the email. If you have any questions please email us at email@example.com.
We are so grateful for all of you who have joined our family last year and we want to celebrate 2021 with you!
Our Speaker Matthew Harms, MD is an Associate Professor of Neurology at Columbia University as well as a neurologist at the Eleanor & Lou Gehrig ALS Center of Excellence. His practice & research include a focus on genomics and the genetics of ALS. Dr. Harms is the Director of the Precision Medicine Initiative at the Institute for Genomic Medicine at Columbia. In that capacity, he is directing an international multi-site effort using whole genome and transcriptome sequencing to bring precision medicine to ALS. The Precision Medicine Initiative will help drive innovation in genomic medicine for research, diagnosis and treatment of genetically based diseases like familial ALS. Dr. Harms is also a Principal investigator of the “Genomic Translation for ALS Care” (“GTAC”) Project. GTAC’s mission is to better understand how different genes contribute to various clinical forms of ALS. This will in turn help researchers design better, more focused clinical trials for the development of more effective treatments. Ultimately, this precision medicine approach will ensure ALS treatments are tailored to each person’s unique genetic makeup.
Dr. Harms received his A.B. in Biology summa cum laude from Harvard University in 1997, and his M.D. from UC San Francisco in 2003. His clinical training in neuromuscular diseases led him into the laboratory of Dr. Robert Baloh, where his post-doctoral research identified the genes responsible for two orphan human diseases- dominant spinal muscular atrophy with lower extremity predominance and limb-girdle muscular dystrophy type 1D. Dr. Harms is board certified in neurology, clinical neurophysiology, and neuromuscular medicine. Prior to his work at Columbia, Dr. Harms led the Washington University Neuromuscular Genetics Project and established his research laboratory to continue harnessing emerging genetic technologies to understand the causes of inherited neuromuscular diseases. The lab focused on motor neuron diseases, including ALS & SMA, and his efforts helped identify more than 5 novel disease genes.
Dr. Harms has received following NIH Grants
- NEW YORK CITY CONSORTIUM FOR PRECISION MEDICINE (Federal Gov) Mar 24 2018 - Feb 28 2023
- INTEGRATED GENOMICS IN CLINICAL ALS (Private) Oct 1 2015 - Dec 31 2020
- BIOGEN IDEC (Private) Nov 1 2014 - Dec 31 2020
- NOVEL EXTRACELLULAR VESICLE AND MOLECULAR BIOMARKERS OF ENVIRONMENTAL EXPOSURE AND DISEASE PROGRESSION IN ALS (Federal Gov) Sep 30 2018 - Sep 29 2020
- CREATE CAPTURE (CLINICAL PROCEDURES TO SUPPORT RESEARCH) (Federal Gov) Sep 30 2019 - Aug 31 2020
We look forward to seeing you at the event!